Systemic Thrombolysis With Recombinant Tissue Plasminogen Activator and Tirofiban in Acute Middle Cerebral Artery Occlusion
- 1 March 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 35 (3), 705-709
- https://doi.org/10.1161/01.str.0000117094.41638.ee
Abstract
Background and Purpose— In acute ischemic stroke, thrombolytic treatment with recombinant tissue plasminogen activator (rtPA) is limited by a concomitant activation of the coagulatory system, leadi...Keywords
This publication has 20 references indexed in Scilit:
- Closure of the Blood-Brain Barrier by Matrix Metalloproteinase Inhibition Reduces rtPA-Mediated Mortality in Cerebral Ischemia With Delayed ReperfusionStroke, 2003
- Thrombolysis With Recombinant Tissue Plasminogen Activator and Tirofiban in StrokeStroke, 2003
- Adjuvant Treatment With a Glycoprotein IIb/IIIa Receptor Inhibitor Increases the Therapeutic Window for Low-Dose Tissue Plasminogen Activator Administration in a Rat Model of Embolic StrokeCirculation, 2003
- Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 HoursStroke, 2002
- Early Dramatic Recovery During Intravenous Tissue Plasminogen Activator InfusionStroke, 2002
- Glycoprotein IIb/IIIa Antagonist, Murine 7E3 F(ab′)2, and Tissue Plasminogen Activator in Focal Ischemia: Evaluation of Efficacy and Risk of Hemorrhage with Combination TherapyJournal of Cerebral Blood Flow & Metabolism, 2002
- Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation.Journal of Clinical Investigation, 1998
- Reperfusion after Thrombolytic Therapy of Embolic Stroke in the Rat: Magnetic Resonance and Biochemical ImagingJournal of Cerebral Blood Flow & Metabolism, 1998
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985